April Cashin-Garbutt

Natural Sciences

April graduated with a first-class honours degree in Natural Sciences from Pembroke College, University of Cambridge. During her time as Editor-in-Chief, News-Medical (2012-2017), she kickstarted the content production process and helped to grow the website readership to over 60 million visitors per year.

Through interviewing global thought leaders in medicine and life sciences, including Nobel laureates, April developed a passion for neuroscience and now works at the Sainsbury Wellcome Centre for Neural Circuits and Behaviour, located within UCL.

See less

Articles from April

Eye donations: what stops people? An interview with Rory Passmore

Despite a shortage of corneas for transplant purposes, our new research reveals that eyes are the one body part we are least likely to donate.

27 Jun 2016

Could artificial intelligence help to combat stress? An interview with Davide Morelli

Stress is actually a bit of a buzzword. The initial definition was “the reaction to changes”, which is why you get stressed also when good things happen, hence the distinction between good stress, eustress, and bad stress, distress.

23 Jun 2016

Molecular diagnostics of the future: an interview with Elaine Warburton, OBE

Firstly, a sample must be transported from the clinic to the laboratory. Simple tests may be undertaken in a small lab within the hospital or clinic, whilst complex testing such as drug susceptibility testing is often done in a large centralized laboratory many miles from the clinic

20 Jun 2016

Zika protection whilst traveling: an interview with Dr Crystal Aguh

The majority of the countries that are affected by the Zika virus are in the Caribbean. Many of the Caribbean Islands, including large islands such as Jamaica, Dominican Republic, Barbados and US Virgin Islands, as well as Mexico and other countries in Central and South America are affected.

16 Jun 2016

How can we defeat drug resistance? An interview with Dr Grania Brigden

The O’Neill report is a wide ranging report recognising anti-microbial resistance (AMR) as a global problem with major public health and economic significance.

15 Jun 2016

Controlling corneal blindness by 2030: an interview with Dr Pravin Vaddavalli

Corneal blindness is estimated to be the second most prevalent cause of blindness in many less developed countries. Globally, bilateral corneal blindness is estimated to afflict 4.9 million persons and accounts for 12% of 39 million blind, utilizing WHO 2010 global blindness data.

13 Jun 2016

Tackling Healthcare Challenges in a Changing World: an Interview with Professor Jeremy Nicholson

As individuals and as populations our risks of getting diseases are determined partly genetically and partly from the environment that we live in. An important part of that environment that mediates between the outside world and the inside world of our bodies is the microbiome.

10 Jun 2016